CHOSA (CHOSA) | Spotlight

Chosa Oncology, Danish -Swedish biotechnology company, has developed the iCIP platform, which includes a liposomal formulation of cisplatin (LiPlaCis) and the companion diagnostic (DRP) tool detecting patients who benefits the most of the cisplatin treatment. The recently achieved clinical phase 2b results mean that the Company is now gearing up the business development activities to find partners for partnership or trade deal.

Quotes for CHOSA Oncology AB

Right Now

+/-: 0.02
%: 3,13%
Latest: 0.66
High: 0.66
Low: 0.66
Volume: 1 000
Turnover (SEK): 660
Market Value (MSEK): 46,8
Time (Latest trade)

Board

CEO

Peter Buhl

Chairperson of the Board

Ingrid Atteryd Heiman

Board

Claus Frisenberg Pedersen
Fred Hirsch
Morten Myrhøj
Neil Goldsmith
Ulla Hald Buhl

Articles of association

News

2025-06-13 13:42:46 Kommuniké från årsstämma den 13 juni 2025 i Chosa Oncology AB
2025-06-13 13:42:46 Bulletin from the annual general meeting on 13 June 2025 in Chosa Oncology AB
2025-06-12 08:45:00 Teckningsperioden i Chosa Oncology AB:s företrädesemission inleds idag – bolaget bjuder in till webbkonferens
2025-06-12 08:45:00 The subscription period in Chosa Oncology AB’s rights issue begins today – the company invites to a webcast presentation
2025-06-10 16:04:19 Chosa Oncology AB offentliggör informationsdokument i samband med företrädesemission av units

News agencies

2025-06-09 06:41:00 Finwire: Chosa Oncology handlas i dag på Spotlight exklusive teckningsrätt i företrädesemission
2025-06-02 09:08:00 Finwire: Chosa Oncology genomför riktad emission och företrädesemission om totalt 20 miljoner kronor
2025-05-30 08:22:22 Finwire: Chosa Oncology rapporterar minskad rörelseförlust
2025-05-23 12:34:56 Finwire: Chosa Oncology ska presentera abstrakt på kongress i oktober
2025-05-13 15:43:28 Finwire: Chosa Oncologys styrelse föreslås till omval

Analysis

Largest Owners

Name	Capital %	Votes %	Date
Buhl Krone Holding ApS	22,04	22,04	2025-03-27
Claus Frisenberg Pedersen	11,68	11,68	2023-01-18
IPO Nordic Fund A/S	8,36	8,36	2025-03-27
Smerud Medical Research International AS	7,48	7,48	2025-03-27
Rutger Arnhult	5,48	5,48	2025-03-27
Nels Holding Aps	4,00	4,00	2025-03-27
Lh\|Lh Invest Aps	2,97	2,97	2025-03-27
Karsgaard Holding Ostervra Aps	2,36	2,36	2025-03-27
Sorgenfri Nr. 1 A/S	2,17	2,17	2025-03-27
Rq Solutions Aps	1,87	1,87	2025-03-27

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

CHOSA Oncology AB